Literature DB >> 11819384

Effect of HCV NS(3) protein on p53 protein expression in hep atocarcinogenesis.

De-Yun Feng, Rui-Xue Chen, Yong Peng, Hui Zheng, Ya-Hui Yan.   

Abstract

AIM:To investigate hepatocarcinogenesis by detecting the effect of HCV NS(3) protein on p53 protein expression in hepatocellular carcinoma (HCC) and pericarcinomatous liver tissue (PCLT).
METHODS: The expression of HCV NS(3) and p53 protein was detected with immunohistochemical technique (SP method) in specimens of HCC and PCLT from 47 patients with negative HBV.
RESULTS: The positive rate of HCV NS(3) protein was lower in HCC (62%) than in PCLT (83%) (P < 0.025). The better differentiaton of cancer cells, the stronger expression of HCV NS(3) protein (P < 0.025). The positive rate of p53 protein in HCC (81%) was higher than in PCLT (47%) (P < 0.025). The worse differentiaton of cancer cells, the stronger expression of p53 protein (P < 0.05). The p53 protein expression was not correlated with the HCV NS(3) protein expression in HCC (P < 0.5), whereas their expression was closely related to PCLT (P < 0.01), and the expression rate of p53 protein in the cases of positive HCV NS(3) protein was higher than that in the cases of negative HCV NS(3) protein.
CONCLUSION: HCV NS(3) protein may exert its hepatocarcinogenic effect in early stage on host cells by endogenous pathway which may bring about mutation of p53 gene and transformation of hepatocytes.

Entities:  

Year:  1999        PMID: 11819384      PMCID: PMC4688499          DOI: 10.3748/wjg.v5.i1.45

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  4 in total

1.  ras p21 expression in the progression of breast cancer.

Authors:  F B Fromowitz; M V Viola; S Chao; S Oravez; Y Mishriki; G Finkel; R Grimson; J Lundy
Journal:  Hum Pathol       Date:  1987-12       Impact factor: 3.466

Review 2.  Hepatitis virus-related hepatocarcinogenesis.

Authors:  O Hino; K Kajino
Journal:  Intervirology       Date:  1994       Impact factor: 1.763

3.  p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.

Authors:  T Teramoto; K Satonaka; S Kitazawa; T Fujimori; K Hayashi; S Maeda
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

4.  Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells.

Authors:  D Sakamuro; T Furukawa; T Takegami
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

  4 in total
  13 in total

1.  Effect of 5-Aza-2'-deoxycytidine on the P16 tumor suppressor gene in hepatocellular carcinoma cell line HepG2.

Authors:  L H Liu; W H Xiao; W W Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.

Authors:  Hu Liu; Yuan Wang; Qing Zhou; Shu-Yu Gui; Xu Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Identification of antigens by monoclonal antibody PD4 and its expression in Escherichia coli.

Authors:  Jin-Ying Ning; Guo-Xun Sun; Su Huang; Hong Ma; Ping An; Lin Meng; Shu-Mei Song; Jian Wu; Cheng-Chao Shou
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

4.  Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein.

Authors:  Qiong-Qiong He; Rui-Xue Cheng; Yi Sun; De-Yun Feng; Zhu-Chu Chen; Hui Zheng
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

5.  Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy.

Authors:  Y C Tang; Y Li; G X Qian
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

6.  Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance.

Authors:  D Y Feng; H Zheng; Y Tan; R X Cheng
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

7.  Detection of hepatitis C virus NS5 protein and genome in Chinese carcinoma of the extrahepatic bile duct and its significance.

Authors:  Ming-Yi Chen; Zhi-Qiang Huang; Le-Zhen Chen; Ya-Bing Gao; Rui-Yun Peng; De-Wen Wang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

8.  Preparation of human single chain Fv antibody against hepatitis C virus E2 protein and its identification in immunohistochemistry.

Authors:  Yan-Wei Zhong; Jun Cheng; Gang Wang; Shuang-Shuang Shi; Li Li; Ling-Xia Zhang; Ju-Mei Chen
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

9.  Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance.

Authors:  Qing-He Nie; Yong-Qian Cheng; Yu-Mei Xie; Yong-Xing Zhou; Xian-Guang Bai; Yi-Zhan Cao
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

10.  Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis.

Authors:  Frank Scholle; Kui Li; Francis Bodola; Masanori Ikeda; Bruce A Luxon; Stanley M Lemon
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.